Julie Robinson, who oversees U.S.-side science on the International Space Station (ISS), names a one-time dark horse as her No. 1 research result to date from the orbiting laboratory. Medical researchers started running experiments in space more than a decade ago to see if working in microgravity would make it possible to encapsulate cancer drugs in tiny bubbles that could be targeted on specific tumors in the body. It turns out that it was, as the crew of ISS Expedition 5 discovered in ...

THIS CONTENT REQUIRES SUBSCRIPTION ACCESS

You must be a paid subscriber to access "Casis Boosts ISS Commercial Research Opportunities".

 

Current Aviation Week Intelligence Network (AWIN) enterprise and individual members: please go to http://awin.aviationweek.com for access.

 

Not currently a subscriber? Click on the "Learn More" button below to view subscription offers.

Already registered? here.